1-11 of 11
H. Dombret
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience.

C. Kelaidi, S. Chevret, S. de Botton, E. Raffoux, A. Guerci, X. Thomas, C. Gardin, A. Pigneux, A. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, S. Meyer-Monard, R. Chelo, T. Pabst, P. Chevalier, F. Maloisel, E. Deconinck, A. Ferrant, D. Bron, N. Fegueux, J. de la Serna, G. Martin, J. Cahn, N. Ifrah, B. Cassinat, H. Dombret, M.A. Sanz, Pierre Fenaux, L. Ades
Journal: Blood
Blood (2007) 110 (11): 1845.
https://doi.org/10.1182/blood.V110.11.1845.1845
Published: 2007
Journal Articles

CEBPA Methylation and Notch1 Mutations Are Common in Immature T-ALLs but Not M0 AML and Cosegregate with TCRG Rearrangement and the TCRgd Lineage.

L. Terriou, R. Ben Abdelali, C. Roumier, J. de Vos, P. Cornillet, O. Nibourel, K. Beldjord, H. Dombret, G. Leverger, V. Asnafi, Claude Preudhomme, E. Macintyre
Journal: Blood
Blood (2007) 110 (11): 2788.
https://doi.org/10.1182/blood.V110.11.2788.2788
Published: 2007
Journal Articles

Prognostic Factors and Response Duration in 419 MDS Treated with Erythropoietin±GCSF: The GFM Experience.

S. Park, C. Kelaidi, S. Grabar, O. Beyne-Rauzy, S. Cheze, V. Bardet, M. Escoffre-Barbe, C. Ravoet, A. Ferrant, N. Vey, H. Dombret, B. Mahe, L. Mannone, L. Legros, L. Aljassem, A. Stamatoullas, D. Vassilief, M.C. Quarre, L. Ades, V. Andrieux, S. Giraudier, S. de Botton, N. Casadevall, P. Fenaux, F. Dreyfus
Journal: Blood
Blood (2006) 108 (11): 522.
https://doi.org/10.1182/blood.V108.11.522.522
Published: 2006
Journal Articles

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials).

C. Kelaidi, L. Ades, S. Chevret, M. A. Sanz, A. Guerci, X. Thomas, S. de Botton, E. Raffoux, C. Rayon, J. de la Serna, A. Ferrant, D. Bron, H. Link, N. Fegueux, D. Bordessoule, F. Rigal-Huguet, A.M. Stoppa, A. Vekhoff, S. Meyer-Monard, M. Fey, S. Castaigne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 890.
https://doi.org/10.1182/blood.V106.11.890.890
Published: 2005
Journal Articles

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results.

L. Ades, MD, M. Sanz, MD, S. Chevret, MD, S. De Botton, MD, G. Martin, MD, E. Raffoux, MD, E. Vellenga, MD, A. Guerci, MD, M. Gonzalez, MD, A. Pigneux, MD, C. Rayon, MD, A.M. Stoppa, MD, J. De la Serna, MD, T. Pabst, MD, S. Meyer-Monard, MD, R. Parodi, MD, J. Bergua, MD, F. Rigal-Huguet, MD, A. Vekhoff, MD, S. Negri, MD, N. Fegueux, MD, A. Ferrant, MD, D. Bron, MD, H. Dombret, MD, L. Degos, MD, P. Fenaux, MD
Journal: Blood
Blood (2005) 106 (11): 544.
https://doi.org/10.1182/blood.V106.11.544.544
Published: 2005
Journal Articles

A Phase II Study of Dasatinib in Patients with Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis or Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Who Are Resistant or Intolerant to Imatinib: The ‘START-L’ CA180015 Study.

Oliver G. Ottmann, G. Martinelli, H. Dombret, H. Kantarjian, A. Hochhaus, B. Simonsson, A. Aloe, A. Apanovitch, N. Shah
Journal: Blood
Blood (2005) 106 (11): 42.
https://doi.org/10.1182/blood.V106.11.42.42
Published: 2005
Journal Articles

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000).

L. Ades, E. Raffoux, S. Chevret, S. de Botton, A. Guerci, A. Pigneux, A.M. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, T. Pabst, S. Meyer-Monard, F. Maloisel, E. Deconinck, D. Caillot, N. Gratecos, J.J. Sotto, A. Ferrant, P. Turlure, X. Thomas, N. Fegueux, P. Brault, O. Reman, P. Chevallier, P. Travade, V. Leblond, G. Leverger, A. Stamatoullas, C. Pautas, B. Beve, C. Chomienne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2004) 104 (11): 391.
https://doi.org/10.1182/blood.V104.11.391.391
Published: 2004
Journal Articles

Incidence, Clinical Features, and Outcome of All Trans -Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

S. De Botton, H. Dombret, M. Sanz, J. San Miguel, D. Caillot, R. Zittoun, M. Gardembas, A. Stamatoulas, E. Condé, A. Guerci, C. Gardin, K. Geiser, D. Cony Makhoul, O. Reman, J. de la Serna, F. Lefrere, C. Chomienne, C. Chastang, L. Degos, P. Fenaux, the European APL Group
Journal: Blood
Blood (1998) 92 (8): 2712–2718.
https://doi.org/10.1182/blood.V92.8.2712
Published: 1998
Journal Articles

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments]

L Degos, H Dombret, C Chomienne, MT Daniel, JM Miclea, C Chastang, S Castaigne, P Fenaux
Journal: Blood
Blood (1995) 85 (10): 2643–2653.
https://doi.org/10.1182/blood.V85.10.2643.bloodjournal85102643
Published: 1995
Journal Articles

Unexpected consistent involvement of V beta gene segments in inappropriate T-cell receptor beta gene rearrangements occurring in B- lineage acute lymphoblastic leukemias

H Dombret, P Loiseau, JC Bories, F Sigaux
Journal: Blood
Blood (1992) 80 (10): 2614–2621.
https://doi.org/10.1182/blood.V80.10.2614.2614
Published: 1992
Journal Articles

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

P Fenaux, S Castaigne, H Dombret, E Archimbaud, M Duarte, P Morel, T Lamy, H Tilly, A Guerci, F Maloisel
Journal: Blood
Blood (1992) 80 (9): 2176–2181.
https://doi.org/10.1182/blood.V80.9.2176.2176
Published: 1992